4/A
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-019666
Chief Scientific Officer gave up 565 shares (to pay taxes)
- Chief Scientific Officer acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rodino-Klapac Louise · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-28 | Shares withheld for taxes : show line 1 in the form | −565 | $86.97 | $49,138 | 6,604 | D |
| 2021-03-03 | Grant or award : show line 2 in the form | +15,000 | 21,780 | D |
Loading xslF345X03/doc4a.xml…